摘要
目的 评价尿吡啶酚和脱氧吡啶酚对恶性肿瘤骨转移患者的临床意义。方法 采用ELISA方法检测了 2 6例局限性恶性肿瘤、3 5例进展期肿瘤骨转移阴性和 3 4例骨转移阳性的尿吡啶酚和脱氧吡啶酚水平。结果 进展期肿瘤尿吡啶酚和脱氧吡啶酚水平明显高于限局性肿瘤 (P <0 .0 5 ) ;进展期肿瘤骨转移阳性尿吡啶酚和脱氧吡啶酚水平又明显高于骨转移阴性 (P <0 .0 5 )。结论 尿吡啶酚和脱氧吡啶酚在评价进展期肿瘤骨转移和骨吸收中发挥作用。
? Objective To evaluate the clinical significance of pyridinoline(PYD) and deoxypyridinoline (DPD) in patients with cancer.Methods Urinary pyridinoline and deoxypyridinoline were measured by ELISA assay in 26 patients with local cancer and 69 advanced cancer patients with or without bone metastases.Results Advanced cancer patiets with or without bone metastases had significantly higher urinary concentrations of PYD and DPD than those of local cancer patients.The concentrations of both cross links were also significantly higher in advanced cancer patients with bone metastases than those without bone metastases.Conclusions These findings suggest that the measurement of PYD and DPD in urine may be useful in assessing bone metastases and bone resorption in cancer patients. 〔
出处
《中国肿瘤临床与康复》
2000年第2期71-72,共2页
Chinese Journal of Clinical Oncology and Rehabilitation
关键词
吡啶酚
脱氧吡啶酚
骨转移
pyridinoline
deoxypyridinoline
bone metastases